Search Videos and More
News
PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients
UT Southwestern is leading research to find ways to extend the benefits of PARP-1 inhibitor maintenance medication to more patients with more forms of ovarian cancer.
Video
MEG-nificent Brains: Mapping the Path to a Cure for Seizures
Learn about MEG technology and how it is used to improve epilepsy surgery outcomes for patients.
News
UT Southwestern Orthopaedic Surgeon First in Texas to Use AR Shoulder Replacement Surgery
UT Southwestern Medical Center is one of just 15 surgical centers in the world using next-generation augmented reality (AR) in the operating room for shoulder arthroplasty.
News
FDA Approval of Belzutifan Culminates 25-year Journey at UTSW from Gene Discovery to a First-in-class Drug
A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.
News
Common Weight-Loss Drug Successfully Targets Fat that Can Endanger Heart Health
A common weight-loss drug successfully targets fat that can endanger heart health.
News
Artificial Intelligence Algorithm Developed to Assess Metastatic Potential in Skin Cancers
Using artificial intelligence (AI), researchers from UT Southwestern have developed a way to accurately predict which skin cancers are highly metastatic.
News
Program offers help for those suffering long after a COVID-19 infection
Stephen Lummus knew he was putting himself at risk when he went to New York last year to help beleaguered hospital workers during the COVID-19 surge. “This could be the last time you see your family,” he remembered thinking.
News
Moyamoya Disease and Syndrome: Knowing the Difference Can Prevent a Stroke
Moyamoya is characterized by narrowed carotid arteries and the growth of tiny, fragile blood vessels that may rupture, causing stroke. It is a rare condition that affects Asian populations more frequently.
Video
Advances in Cystic Fibrosis Care and Life Expectancy
Raksha Jain, M.D., the Medical Director of the Adult Cystic Fibrosis Program at UT Southwestern, is at the forefront of improving treatments for cystic fibrosis patients, who are living longer and better lives.
News
Landmark Cystic Fibrosis Clinical Trial Gives Patients Hope for Healthy Pregnancies
Just 20 years ago, patients with cystic fibrosis (CF) were not expected to live past age 40, let alone carry a healthy pregnancy to term. Today, medical advancements such as the breakthrough CF drug TRIKAFTA are helping more adults live longer, healthier lives.
News
UT Southwestern Center for Depression Research and Clinical Care Partnering on Lone Star Depression Challenge
UT Southwestern Medical Center’s Center for Depression Research and Clinical Care is collaborating with mental health colleagues across the country to expand detection and treatment for depression and other disorders across Texas as part of the Lone Star Depression Challenge.
News
Giving Brown Fat a Boost to Fight Type 2 Diabetes
Increasing a protein concentrated in brown fat appears to lower blood sugar, promote insulin sensitivity, and protect against fatty liver disease by remodeling white fat to a healthier state, a new study led by UT Southwestern scientists suggests.